COMMISSION IMPLEMENTING REGULATION (EU) 2022/159
of 4 February 2022
approving the low-risk active substance
Bacillus amyloliquefaciens
strain IT-45 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011
(Text with EEA relevance)
Article 1
Approval of the active substance
Article 2
Amendments to Implementing Regulation (EU) No 540/2011
Article 3
Entry into force
ANNEX I
Common Name, Identification Numbers |
IUPAC Name |
Purity(1) |
Date of approval |
Expiration of approval |
Specific provisions |
Bacillus amyloliquefaciens IT-45 |
n.a. |
The nominal content of Bacillus amyloliquefaciens IT-45 in the technical product and formulation is: minimum: 2 x 1013 CFU/kg, maximum: 6 x 1014 CFU/kg. No relevant impurities |
27 February 2022 |
27 February 2037 |
For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Bacillus amyloliquefaciens IT-45 shall be taken into account. |
ANNEX II
No. |
Common Name, Identification Numbers |
IUPAC Name |
Purity(1) |
Date of approval |
Expiration of approval |
Specific provisions |
‘35 |
Bacillus amyloliquefaciens IT-45 |
n.a. |
The nominal content of Bacillus amyloliquefaciens IT-45 in the technical product and formulation is: minimum: 2 x 1013 CFU/kg, maximum: 6 x 1014 CFU/kg. No relevant impurities |
27 February 2022 |
27 February 2037 |
For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Bacillus amyloliquefaciens IT-45 shall be taken into account. |